vs

Side-by-side financial comparison of Hyperscale Data, Inc. (GPUS) and Pulmonx Corp (LUNG). Click either name above to swap in a different company.

Hyperscale Data, Inc. is the larger business by last-quarter revenue ($26.9M vs $20.6M, roughly 1.3× Pulmonx Corp). Pulmonx Corp runs the higher net margin — -66.3% vs -112.0%, a 45.6% gap on every dollar of revenue. On growth, Hyperscale Data, Inc. posted the faster year-over-year revenue change (38.4% vs -8.7%). Over the past eight quarters, Pulmonx Corp's revenue compounded faster (-0.5% CAGR vs -16.3%).

Hyperscale Data, Inc. provides GPU-accelerated computing infrastructure and cloud solutions tailored for AI development, big data processing, and high-performance computing workloads. It primarily serves AI startups, large technology firms, and cloud service providers across North America and the Asia-Pacific region, delivering scalable, high-efficiency computing resources to support complex data processing needs.

Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.

GPUS vs LUNG — Head-to-Head

Bigger by revenue
GPUS
GPUS
1.3× larger
GPUS
$26.9M
$20.6M
LUNG
Growing faster (revenue YoY)
GPUS
GPUS
+47.0% gap
GPUS
38.4%
-8.7%
LUNG
Higher net margin
LUNG
LUNG
45.6% more per $
LUNG
-66.3%
-112.0%
GPUS
Faster 2-yr revenue CAGR
LUNG
LUNG
Annualised
LUNG
-0.5%
-16.3%
GPUS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GPUS
GPUS
LUNG
LUNG
Revenue
$26.9M
$20.6M
Net Profit
$-30.1M
$-13.7M
Gross Margin
14.5%
77.9%
Operating Margin
-117.8%
-40.9%
Net Margin
-112.0%
-66.3%
Revenue YoY
38.4%
-8.7%
Net Profit YoY
-6670.3%
5.5%
EPS (diluted)
$-0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GPUS
GPUS
LUNG
LUNG
Q1 26
$20.6M
Q4 25
$26.9M
$22.6M
Q3 25
$24.3M
$21.5M
Q2 25
$25.9M
$23.9M
Q1 25
$25.0M
$22.5M
Q4 24
$19.4M
$23.8M
Q3 24
$31.1M
$20.4M
Q2 24
$17.8M
$20.8M
Net Profit
GPUS
GPUS
LUNG
LUNG
Q1 26
$-13.7M
Q4 25
$-30.1M
$-10.4M
Q3 25
$-13.0M
$-14.0M
Q2 25
$-19.1M
$-15.2M
Q1 25
$-4.2M
$-14.4M
Q4 24
$-445.0K
$-13.2M
Q3 24
$-25.5M
$-14.1M
Q2 24
$-33.9M
$-15.3M
Gross Margin
GPUS
GPUS
LUNG
LUNG
Q1 26
77.9%
Q4 25
14.5%
77.6%
Q3 25
25.8%
74.7%
Q2 25
23.7%
72.1%
Q1 25
21.1%
72.5%
Q4 24
6.5%
74.0%
Q3 24
27.5%
73.7%
Q2 24
-21.3%
73.7%
Operating Margin
GPUS
GPUS
LUNG
LUNG
Q1 26
-40.9%
Q4 25
-117.8%
-43.8%
Q3 25
-57.8%
-66.9%
Q2 25
-39.2%
-62.0%
Q1 25
-25.5%
-64.6%
Q4 24
-46.8%
-56.5%
Q3 24
-79.2%
-69.3%
Q2 24
-151.4%
-75.2%
Net Margin
GPUS
GPUS
LUNG
LUNG
Q1 26
-66.3%
Q4 25
-112.0%
-46.1%
Q3 25
-53.5%
-64.9%
Q2 25
-73.7%
-63.6%
Q1 25
-16.8%
-64.1%
Q4 24
-2.3%
-55.4%
Q3 24
-82.3%
-69.4%
Q2 24
-190.7%
-73.7%
EPS (diluted)
GPUS
GPUS
LUNG
LUNG
Q1 26
$-0.33
Q4 25
$-0.25
Q3 25
$-0.39
$-0.34
Q2 25
$-2.66
$-0.38
Q1 25
$-0.36
Q4 24
$-8.78
$-0.33
Q3 24
$-24.82
$-0.36
Q2 24
$-37.81
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GPUS
GPUS
LUNG
LUNG
Cash + ST InvestmentsLiquidity on hand
$13.1M
$61.6M
Total DebtLower is stronger
$83.1M
$37.3M
Stockholders' EquityBook value
$119.8M
$45.8M
Total Assets
$313.7M
$120.0M
Debt / EquityLower = less leverage
0.69×
0.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GPUS
GPUS
LUNG
LUNG
Q1 26
$61.6M
Q4 25
$13.1M
$69.8M
Q3 25
$24.8M
$76.5M
Q2 25
$5.9M
$75.5M
Q1 25
$4.2M
$74.6M
Q4 24
$4.5M
$70.9M
Q3 24
$7.9M
$63.3M
Q2 24
$9.6M
$63.5M
Total Debt
GPUS
GPUS
LUNG
LUNG
Q1 26
$37.3M
Q4 25
$83.1M
$37.1M
Q3 25
$80.0M
$37.1M
Q2 25
$88.5M
$37.1M
Q1 25
$92.8M
$37.2M
Q4 24
$96.7M
$37.2M
Q3 24
$104.8M
$37.2M
Q2 24
$106.8M
$37.2M
Stockholders' Equity
GPUS
GPUS
LUNG
LUNG
Q1 26
$45.8M
Q4 25
$119.8M
$54.1M
Q3 25
$55.9M
$60.0M
Q2 25
$5.5M
$69.1M
Q1 25
$6.3M
$77.7M
Q4 24
$8.6M
$85.8M
Q3 24
$2.7M
$93.9M
Q2 24
$26.7M
$101.2M
Total Assets
GPUS
GPUS
LUNG
LUNG
Q1 26
$120.0M
Q4 25
$313.7M
$129.3M
Q3 25
$242.4M
$138.3M
Q2 25
$213.5M
$147.2M
Q1 25
$218.5M
$150.7M
Q4 24
$220.8M
$162.8M
Q3 24
$231.5M
$167.4M
Q2 24
$270.8M
$172.6M
Debt / Equity
GPUS
GPUS
LUNG
LUNG
Q1 26
0.82×
Q4 25
0.69×
0.69×
Q3 25
1.43×
0.62×
Q2 25
16.06×
0.54×
Q1 25
14.71×
0.48×
Q4 24
11.19×
0.43×
Q3 24
38.41×
0.40×
Q2 24
4.00×
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GPUS
GPUS
LUNG
LUNG
Operating Cash FlowLast quarter
$-37.7M
Free Cash FlowOCF − Capex
$-56.2M
FCF MarginFCF / Revenue
-208.7%
Capex IntensityCapex / Revenue
68.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-87.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GPUS
GPUS
LUNG
LUNG
Q1 26
Q4 25
$-37.7M
$-7.1M
Q3 25
$-17.8M
$-8.2M
Q2 25
$-3.1M
$-3.9M
Q1 25
$-4.0M
$-13.2M
Q4 24
$-9.2M
$-6.7M
Q3 24
$3.7M
$-7.2M
Q2 24
$-3.7M
$-5.8M
Free Cash Flow
GPUS
GPUS
LUNG
LUNG
Q1 26
Q4 25
$-56.2M
$-7.1M
Q3 25
$-20.6M
$-8.3M
Q2 25
$-3.5M
$-4.0M
Q1 25
$-6.8M
$-13.5M
Q4 24
$-9.3M
$-6.8M
Q3 24
$2.6M
$-7.7M
Q2 24
$-5.9M
$-6.2M
FCF Margin
GPUS
GPUS
LUNG
LUNG
Q1 26
Q4 25
-208.7%
-31.4%
Q3 25
-84.5%
-38.4%
Q2 25
-13.5%
-16.6%
Q1 25
-27.3%
-60.0%
Q4 24
-47.6%
-28.8%
Q3 24
8.4%
-37.6%
Q2 24
-33.4%
-30.0%
Capex Intensity
GPUS
GPUS
LUNG
LUNG
Q1 26
Q4 25
68.6%
0.1%
Q3 25
11.5%
0.4%
Q2 25
1.5%
0.2%
Q1 25
11.5%
1.3%
Q4 24
0.3%
0.5%
Q3 24
3.6%
2.0%
Q2 24
12.6%
2.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GPUS
GPUS

Transferred Over Time$10.4M39%
Revenue From Mined Crypto Assets At Sentinum Owned And Operated Facilities$5.8M21%
Hotel And Real Estate Operations$4.8M18%
Other$4.0M15%
Turn On Green$2.0M7%

LUNG
LUNG

Segment breakdown not available.

Related Comparisons